主動脈血管支架市場規模、佔有率和成長分析(按產品、最終用戶和地區分類)—產業預測(2026-2033 年)
市場調查報告書
商品編碼
1896011

主動脈血管支架市場規模、佔有率和成長分析(按產品、最終用戶和地區分類)—產業預測(2026-2033 年)

Aortic Stent Grafts Market Size, Share, and Growth Analysis, By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End User (Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球主動脈血管支架市場規模預計在 2024 年達到 33.5 億美元,從 2025 年的 35.1 億美元成長到 2033 年的 50.6 億美元,在預測期(2026-2033 年)內複合年成長率為 4.7%。

全球主動脈血管支架市場正經歷顯著成長,主要受主動脈瘤發生率上升和心血管疾病日益增多的推動。患者越來越傾向於選擇血管內治療而非傳統開放性手術,這得益於微創手術帶來的更快康復和更少不適感,從而推動了胸主動脈瘤和腹部主動脈血管瘤修復的需求。都市化加快、研發投入增加以及醫療基礎設施改善均對市場動態正面影響。然而,一些挑戰,例如對新型血管內修復術(EVAR)的認知度較低、內漏等併發症風險以及某些地區熟練醫務人員短缺等,可能會阻礙市場擴張。儘管有這些挑戰,血管支架設計的創新進展仍為市場相關人員提供了充滿希望的機會。

全球主動脈血管支架市場促進因素

由於幾個關鍵因素,全球主動脈血管支架市場預計將迎來顯著成長。其中,患者越來越傾向於選擇血管內修復而非傳統開放性手術是主要影響因素,其次是預期壽命的延長和微創手術的普及。此外,旨在提升此類醫療設備性能的臨床試驗數量顯著增加,以及創新型主動脈血管支架設計獲得監管部門核准,這些因素共同促成了積極的市場前景,並推動了技術和治療方案的進步,從而造福患者。

限制全球主動脈血管支架市場的因素

全球主動脈血管支架市場的發展面臨許多重大挑戰。合格醫療專業人員的嚴重短缺阻礙了這些器械的有效應用。此外,醫療專業人員對最新血管內動脈瘤修復術(EVAR)技術的訓練不足,也導致他們不願意採用新的治療方法。再者,對潛在併發症(例如內漏和其他與主動脈血管支架手術相關的不利事件)的擔憂,也可能使醫療服務提供者和患者望而卻步。這些因素疊加在一起,有可能限制市場的擴張及其全部潛力的發揮。

全球主動脈血管支架市場趨勢

受人口老化、主動脈瘤發生率上升以及醫療技術進步等多種因素的影響,全球主動脈血管支架市場呈現穩定上升的趨勢。心臟病負擔日益加重,促使醫療機構尋求有效的治療方案,從而推動了對創新血管支架物產品的需求。此外,監管核准流程的日益高效,也促進了新技術進入市場。消費者對支架和移植物器械的益處和選擇的認知不斷提高,也進一步推動了市場發展,預計這將在不久的將來推動市場實現顯著成長和發展。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球主動脈血管支架市場規模(按產品和複合年成長率分類)(2026-2033 年)

  • 腹主動脈血管支架
  • 胸主動脈血管支架

全球主動脈血管支架市場規模(依最終用戶分類)及複合年成長率(2026-2033 年)

  • 醫院
  • 門診手術中心

全球主動脈血管支架市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Medtronic(Ireland)
  • WL Gore & Associates, Inc.(USA)
  • Cook Medical(USA)
  • Terumo Aortic(Japan)
  • Endologix LLC(USA)
  • Jotec(Germany)
  • MicroPort Scientific Corporation(China)
  • Corcym(Italy)
  • Edwards Lifesciences Corporation(USA)
  • Bentley Healthcare Pvt. Ltd.(India)
  • Braile Biomedica(Brazil)
  • Cardinal Health(USA)
  • InSitu Technologies Inc.(USA)
  • Artivion Inc.(USA)
  • Cryolife Inc.(USA)
  • Lombard Medical Inc.(UK)
  • Bolton Medical(Spain)

結論與建議

簡介目錄
Product Code: SQMIG35B2078

Global Aortic Stent Grafts Market size was valued at USD 3.35 Billion in 2024 and is poised to grow from USD 3.51 Billion in 2025 to USD 5.06 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global aortic stent graft market is witnessing significant growth driven by the increasing prevalence of aortic aneurysms and rising cardiovascular diseases. As patients lean towards endovascular repair over traditional open surgeries, the demand for thoracic and abdominal aneurysm repairs grows, fueled further by the preference for minimally invasive procedures that promise quicker recovery and less discomfort. Urbanization, increased research and development efforts, and improvements in healthcare infrastructure contribute positively to market dynamics. However, challenges such as limited awareness regarding new EVAR treatments, the potential risk of complications like endoleaks, and a shortage of skilled healthcare professionals in certain regions could impede market expansion. Despite these challenges, innovative advancements in stent graft designs present promising opportunities for market players.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Stent Grafts Market Segments Analysis

Global Aortic Stent Grafts Market is segmented by Product, End User and region. Based on Product, the market is segmented into Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Stent Grafts Market

The global aortic stent grafts market is expected to experience significant growth driven by several key factors. The rising preference for endovascular repair techniques over traditional open surgeries is a major influence, alongside an increase in life expectancy and the growing trend toward minimally invasive surgical procedures. Additionally, there is a notable rise in the number of clinical trials aimed at enhancing these medical devices, coupled with the approval of innovative aortic stent graft designs by regulatory authorities. Collectively, these elements contribute to a positive outlook for the market, fostering advancements in technology and treatment options for patients.

Restraints in the Global Aortic Stent Grafts Market

The growth of the Global Aortic Stent Grafts market faces several significant challenges. A notable shortfall in appropriately skilled healthcare professionals hinders the effective implementation of these devices. Additionally, insufficient training regarding the latest endovascular aneurysm repair (EVAR) techniques contributes to reluctance among practitioners to adopt new treatments. Furthermore, concerns surrounding potential complications, such as endoleaks and other adverse effects associated with aortic stent graft procedures, may deter both healthcare providers and patients. This combination of factors could limit the market's ability to expand and fully realize its potential.

Market Trends of the Global Aortic Stent Grafts Market

The Global Aortic Stent Grafts market is witnessing a robust upward trend, driven by various factors including an aging population, escalating rates of aortic aneurysms, and advancements in medical technology. The increasing burden of cardiac disorders is prompting healthcare providers to seek effective treatment solutions, thereby enhancing demand for innovative stent graft products. Additionally, regulatory approvals are becoming more streamlined, facilitating quicker market entry for new technologies. Heightened consumer awareness regarding the benefits and options available in stent and graft devices further underscores the market's momentum, positioning it for significant growth and development in the foreseeable future.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Aortic Stent Grafts Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Abdominal Aortic Stent Graft
  • Thoracic Aortic Stent Graft

Global Aortic Stent Grafts Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers

Global Aortic Stent Grafts Market Size & CAGR (2026-2033)

  • North America (Product, End User)
    • US
    • Canada
  • Europe (Product, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Aortic (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jotec (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corcym (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bentley Healthcare Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Braile Biomedica (Brazil)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InSitu Technologies Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Artivion Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cryolife Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lombard Medical Inc. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bolton Medical (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations